부산대학교 도서관

Strati, Paolo, MD; Castro, Januario, MD; Goodman, Aaron, MD; Bachanova, Veronika, Prof; Kamdar, Manali, MD; Awan, Farrukh T, MD; Solomon, Scott R, MD; Wong, Lilly, PhD; Wong, Carol, MPH; Patel, Deepa, BS; Bickers, Cara, PhD; Zhao, Wei, PhD; Bashir, Zahid, MD; Valamehr, Bahram, PhD; Elstrom, Rebecca L, MD; Patel, Krish, MD

The Lancet Haematology. 12(7):e505-e515

Ghobadi, Armin, Prof; Bachanova, Veronika, Prof; Patel, Krish, MD; Park, Jae H, MD; Flinn, Ian, MD; Riedell, Peter A, MD; Bachier, Carlos, MD; Diefenbach, Catherine S, MD; Wong, Carol, MPH; Bickers, Cara, PhD; Wong, Lilly, PhD; Patel, Deepa, BPharm Hons; Goodridge, Jode, PhD; Denholt, Matthew, PhD; Valamehr, Bahram, PhD; Elstrom, Rebecca L, MD; Strati, Paolo, MD

The Lancet. 405(10473):127-136

Moles MW; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Erdlei H; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Menzel L; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Massaro M; Microenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center, Berlin, Germany.; Fiori A; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Bunse M; Microenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center, Berlin, Germany.; Schrimpf M; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Gerlach K; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.; Gudipati V; Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria.; Reiser J; Fate Therapeutics, San Diego, CA, United States.; Mathavan K; Fate Therapeutics, San Diego, CA, United States.; Goodrich JP; Fate Therapeutics, San Diego, CA, United States.; Huppa JB; Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria.; Krönke J; Department of Hematology, Oncology and Tumorimmunology, Charité-University Medicine Berlin, Berlin, Germany.; Valamehr B; Fate Therapeutics, San Diego, CA, United States.; Höpken UE; Microenvironmental Regulation in Autoimmunity and Cancer, Max Delbrück Center, Berlin, Germany.; Rehm A; Translational Tumorimmunology, Max Delbrück Center, Berlin, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Fiori A; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany.; Zimmermann K; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany.; Li A; Max-Delbrück-Center for Molecular Medicine, Department of Microenvironmental Regulation in Autoimmunity and Cancer, 13125 Berlin, Germany.; Westermann J; Charité-University Medicine Berlin, Department of Hematology, Oncology and Tumorimmunology, Campus Virchow Klinikum, 13353 Berlin, Germany.; Anagnostopoulos I; University of Würzburg, Institute of Pathology, 97080 Würzburg, Germany.; Menzel L; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany.; Bunse M; Max-Delbrück-Center for Molecular Medicine, Department of Microenvironmental Regulation in Autoimmunity and Cancer, 13125 Berlin, Germany.; Erdlei H; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany.; Jayarajan J; Max-Delbrück-Center for Molecular Medicine, Department of Microenvironmental Regulation in Autoimmunity and Cancer, 13125 Berlin, Germany.; Grünschläger F; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Ortiz-Aguirre JP; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany; Charité-University Medicine Berlin, Department of Hematology, Oncology and Tumorimmunology, Campus Virchow Klinikum, 13353 Berlin, Germany.; Haas S; Berlin Institute of Health (BIH), 10178 Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, BIMSB, Berlin, Germany; Charité-University Medicine Berlin, Department of Hematology, Oncology and Tumorimmunology, Campus Benjamin Franklin, 12203 Berlin, Germany; Precision Healthcare University Research Institute, Queen Mary University of London, London E1 1HH, UK.; Teßmann UJ; Helios Klinik Berlin-Buch, Department of Trauma Surgery, 13125 Berlin, Germany.; Freitag J; Helios Klinik Berlin-Buch, Department of Trauma Surgery, 13125 Berlin, Germany.; Rosenwald A; University of Würzburg, Institute of Pathology, 97080 Würzburg, Germany.; Kwak L; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.; Wang X; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.; Dong Z; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.; Cha S; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.; Reiser J; Fate Therapeutics, San Diego, CA 92131, USA.; Peralta E; Fate Therapeutics, San Diego, CA 92131, USA.; Valamehr B; Fate Therapeutics, San Diego, CA 92131, USA.; Krönke J; Charité-University Medicine Berlin, Department of Hematology, Oncology and Tumorimmunology, Campus Benjamin Franklin, 12203 Berlin, Germany.; Höpken UE; Max-Delbrück-Center for Molecular Medicine, Department of Microenvironmental Regulation in Autoimmunity and Cancer, 13125 Berlin, Germany.; Rehm A; Max-Delbrück-Center for Molecular Medicine, Department of Translational Tumorimmunology, 13125 Berlin, Germany. Electronic address: arehm@mdc-berlin.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Bachanova, V.; Deol, A.; Al‐Juhaishi, T.; Lulla, P.; Byrne, M.; Pancari, P.; Stevens, D.; Ghobadi, A.; Schiller, G.; Iragavarapu, C.; Wong, C.; Bickers, C.; Greene, T.; Wong, L.; Villa, B.; Patel, D.; Valamehr, B.; Elstrom, R. L.; Lunning, M.

Hematological Oncology (HEMATOL ONCOL), 2025 Supplement; 43: 1-2. (2p)

Cichocki, F; Valamehr, B; Bjordahl, R; Zhang, B; Rezner, B; Rogers, P; Gaidarova, S; Moreno, S; Tuininga, K; Dougherty, P

CANCER RESEARCH. 77(20):5664-5675

Goulding, J.; Yeh, W.-I.; Hancock, B.; Blum, R.; Xu, T.; Yang, B.-H.; Chang, C.-W.; Groff, B.; Avramis, E.; Pribadi, M.; Pan, Y.; Chu, H.-Y.; Sikaroodi, S.; Fong, L.; Brookhouser, N.; Dailey, T.; Meza, M.; Denholtz, M.; Diaz, E.; Martin, J.; Szabo, P.; Cooley, S.; Lee, T.T.; Bjordahl, R.; Valamehr, B.; Ferrari de Andrade, L.; Wucherpfennig, K.W.

In: Med. (Med, 14 July 2023, 4(7):457-477.e8)

Cichocki F; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Bjordahl R; Fate Therapeutics, San Diego, CA, 92121, USA.; Goodridge JP; Fate Therapeutics, San Diego, CA, 92121, USA.; Mahmood S; Fate Therapeutics, San Diego, CA, 92121, USA.; Gaidarova S; Fate Therapeutics, San Diego, CA, 92121, USA.; Abujarour R; Fate Therapeutics, San Diego, CA, 92121, USA.; Davis ZB; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Merino A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Tuininga K; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Wang H; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Kumar A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.; Groff B; Fate Therapeutics, San Diego, CA, 92121, USA.; Witty A; Fate Therapeutics, San Diego, CA, 92121, USA.; Bonello G; Fate Therapeutics, San Diego, CA, 92121, USA.; Huffman J; Fate Therapeutics, San Diego, CA, 92121, USA.; Dailey T; Fate Therapeutics, San Diego, CA, 92121, USA.; Lee TT; Fate Therapeutics, San Diego, CA, 92121, USA.; Malmberg KJ; Oslo University Hospital, Oslo, Norway.; Walcheck B; University of Minnesota, Department of Veterinary and Biomedical Sciences, St. Paul, MN, 55108, USA.; Höpken U; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.; Rehm A; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.; Valamehr B; Fate Therapeutics, San Diego, CA, 92121, USA. bob.valamehr@fatetherapeutics.com.; Miller JS; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA. mille011@umn.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Kate J. Dixon; Kristin M. Snyder; Melissa Khaw; Robert Hullsiek; Zachary B. Davis; Anders W. Matson; Soheila Shirinbak; Bryan Hancock; Ryan Bjordahl; Martin Hosking; Jeffrey S. Miller; Bahram Valamehr; Jianming Wu; Bruce Walcheck

Frontiers in Immunology, Vol 15 (2024)

Kanaya M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Philippon C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Netskar H; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Saetersmoen ML; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Cieslar-Pobuda A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Torralba-Raga L; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Casoni GP; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Hammer Q; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Vincenti M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Wiiger MT; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Krokeide SZ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Hoel HJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Ask EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Kosugi-Kanaya M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Kveberg L; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Chu HY; Fate Therapeutics, San Diego, CA, USA.; Groff B; Fate Therapeutics, San Diego, CA, USA.; Miller JS; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.; Lee T; Fate Therapeutics, San Diego, CA, USA.; Kaufman DS; Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA.; Goodridge JP; Fate Therapeutics, San Diego, CA, USA.; Valamehr B; Fate Therapeutics, San Diego, CA, USA.; Pfefferle A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Malmberg KJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Yang BH; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Gutierrez A; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Liao A; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Shirinbak S; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Gaertner B; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Pribadi M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Chu HY; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Tsai PF; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Lin YE; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Gonzalez D; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Yeh WI; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Chang CW; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Bjordahl R; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Lee T; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Hosking M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Peralta E; Fate Therapeutics, Inc., San Diego, CA 92131, USA. Electronic address: eigen.peralta@fatetherapeutics.com.; Valamehr B; Fate Therapeutics, Inc., San Diego, CA 92131, USA. Electronic address: bob.valamehr@fatetherapeutics.com.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Ma L; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Koehn B; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Zaiken M; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Hippen KL; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Smith K; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Allred J; Department of Medicine, University of Minnesota, Minneapolis, MN.; Williams R; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Yao K; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Fink J; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Saha A; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Koop B; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Payne N; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Widelak R; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Panoskaltsis-Mortari A; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Riddle MJ; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Tolar J; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Eide C; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Xia L; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Witty AD; Fate Therapeutics, San Diego, CA.; Mehta AK; Fate Therapeutics, San Diego, CA.; Denholtz M; Fate Therapeutics, San Diego, CA.; Hefazi M; T Cell Engineering Laboratory and the Division of Hematology, Mayo Clinic, Rochester, MN.; Hani S; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Kenderian SS; T Cell Engineering Laboratory and the Division of Hematology, Mayo Clinic, Rochester, MN.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN.; Department Immunology, Mayo Clinic, Rochester, MN.; Miller JS; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.; Molldrem JJ; ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX.; Kean LS; Division of Pediatric Hematology and Oncology, Boston Children's Hospital, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Valamehr B; Fate Therapeutics, San Diego, CA.; Blazar BR; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Goulding, J. ; Reiser, J. ; O'Connor, A. ; Morales-Mantilla, D. ; Mbofung, R. ; Williams, A. ; Gutierrez, A. ; Jelcic, M. ; Pan, Y. ; Groff, B. ; Macia, A. ; Brookhouser, N. ; Greene, T. ; Raman, S. ; Janani, R. ; Hancock, B. ; Denholtz, M. ; Rezner, B. ; Abujarour, R. ; Wong, L. ; Sandhu, V. ; Lee, T. ; Valamehr, B. ; Goodridge, J.

In Annals of the Rheumatic Diseases June 2025 84 Supplement 1:368-368

Sandhu, V. ; Fazeli, P. ; Medlin, J. ; Zack, D. ; Elstrom, R. ; BitMansour, A. ; Villa, B. ; Wong, L. ; Goulding, J. ; Brookhouser, N. ; Greene, T. ; Bickers, C. ; Wong, C. ; Stewart, J. ; Lee, T. ; Goodridge, J. ; Hu, M. ; Bachanova, V. ; Miller, J.S. ; Lunning, M. ; Valamehr, B.

In Annals of the Rheumatic Diseases June 2025 84 Supplement 1:29-30

Eckstrom A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tyagi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mahmood S; Fate Therapeutics, Inc., San Diego, California, USA.; Wong L; Fate Therapeutics, Inc., San Diego, California, USA.; Valamehr B; Fate Therapeutics, Inc., San Diego, California, USA.; Rao A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Agrawal A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Siddiqui M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE

Saetersmoen, ML; Hammer, Q; Valamehr, B; Kaufman, DS; Malmberg, K-J

SEMINARS IN IMMUNOPATHOLOGY. 41(1):59-68

Lu D; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Chu HY; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Park S; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Landon M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Tsuda M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Avramis E; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Dege C; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Dailey T; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Pan Y; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Hanok SK; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Denholtz M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Abujarour R; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Lee T; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Goulding J; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Hosking M; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Goodridge J; Fate Therapeutics, Inc., San Diego, CA 92131, USA.; Peralta E; Fate Therapeutics, Inc., San Diego, CA 92131, USA. Electronic address: eigen.peralta@fatetherapeutics.com.; Valamehr B; Fate Therapeutics, Inc., San Diego, CA 92131, USA. Electronic address: bob.valamehr@fatetherapeutics.com.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Hosking MP; Fate Therapeutics, Inc., San Diego, CA, USA. Electronic address: martin.hosking@fatetherapeutics.com.; Shirinbak S; Fate Therapeutics, Inc., San Diego, CA, USA.; Omilusik K; Fate Therapeutics, Inc., San Diego, CA, USA.; Chandra S; Fate Therapeutics, Inc., San Diego, CA, USA.; Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.; Gentile A; Fate Therapeutics, Inc., San Diego, CA, USA.; Yamamoto S; Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.; Shrestha B; Fate Therapeutics, Inc., San Diego, CA, USA.; Grant J; Fate Therapeutics, Inc., San Diego, CA, USA.; Boyett M; Fate Therapeutics, Inc., San Diego, CA, USA.; Cardenas D; Fate Therapeutics, Inc., San Diego, CA, USA.; Keegan H; Fate Therapeutics, Inc., San Diego, CA, USA.; Ibitokou S; Fate Therapeutics, Inc., San Diego, CA, USA.; Pavon C; Fate Therapeutics, Inc., San Diego, CA, USA.; Mizoguchi T; Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.; Ihara T; Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.; Nakayama D; Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.; Abujarour R; Fate Therapeutics, Inc., San Diego, CA, USA.; Lee TT; Fate Therapeutics, Inc., San Diego, CA, USA.; Clarke R; Fate Therapeutics, Inc., San Diego, CA, USA.; Goodridge J; Fate Therapeutics, Inc., San Diego, CA, USA.; Peralta E; Fate Therapeutics, Inc., San Diego, CA, USA.; Maeda T; Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.; Takagi J; Institute for Protein Research, Osaka University, 3-2, Yamadaoka, Suita 565-0871, Osaka, Japan.; Arimori T; Institute for Protein Research, Osaka University, 3-2, Yamadaoka, Suita 565-0871, Osaka, Japan.; Kato Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.; Valamehr B; Fate Therapeutics, Inc., San Diego, CA, USA. Electronic address: bob.valamehr@fatetherapeutics.com.

Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE

Greene, T. ; Peng, S. ; Bickers, C. ; Lunning, M. ; Lulla, P. ; Bachanova, V. ; Williams, A. ; Morales-Mantilla, D. ; Mbofung, R. ; Aguilar, A. ; Brookhouser, N. ; Reeder, S. ; Zhao, W. ; Patel, D. ; Abujarour, R. ; Lee, T. ; Clarke, R. ; Rezner, B. ; Goodridge, J. ; Elstrom, R. ; Zack, D. ; Sandhu, V. ; Valamehr, B. ; Wong, L.

In Annals of the Rheumatic Diseases June 2025 84 Supplement 1:1423-1424

Zhu H; Department of Medicine, University of California, San Diego, La Jolla, CA.; Blum RH; Department of Medicine, University of California, San Diego, La Jolla, CA.; Bjordahl R; Fate Therapeutics, San Diego, CA.; Gaidarova S; Fate Therapeutics, San Diego, CA.; Rogers P; Fate Therapeutics, San Diego, CA.; Lee TT; Fate Therapeutics, San Diego, CA.; Abujarour R; Fate Therapeutics, San Diego, CA.; Bonello GB; Fate Therapeutics, San Diego, CA.; Wu J; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN; and.; Tsai PF; Fate Therapeutics, San Diego, CA.; Miller JS; Department of Medicine and Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN; and.; Valamehr B; Fate Therapeutics, San Diego, CA.; Kaufman DS; Department of Medicine, University of California, San Diego, La Jolla, CA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE